COVID-19 – what have we learned? 1600-OG-EN-C19

During the course students get familiar with the basic information regarding novel coronavirus SARS-COV2, its structure, live cycle and virulence. During the seminar, the disease COVID-19 will be discussed along with symptoms and course of the disease. The newest treatment strategies for COVID-19 will also be discussed with particular emphasis of efficacy and safety of strategies. Eventually, the role of clinical trials and using evidence-based medicine principles during the pandemic and potential fields for development of new treatment will be presented.

Całkowity nakład pracy studenta

Study hours involving teacher participation: - participation in the seminar – 15 hours (including 15 hours realized in the form of e-learning) - consultation with an academic teacher - 3 hours Study hours involving individual student work: - preparation for seminars - 6 hours - reading literature – 2 hours - preparation for test - 4 hours The total student workload is 30 hours, which corresponds to 1 ECTS.

Efekty uczenia się - wiedza

Student: W1: Knows and understands the basic information regarding SARS-COV2 virus and its virulence. W2: Knows and understands the information regarding COVID-19 symptoms, course of the disease and currently available treatment options.

Efekty uczenia się - umiejętności

Student: U1: Is able to further develop his/her knowledge regarding SARS-COV2 and COVID19.

Efekty uczenia się - kompetencje społeczne

Student: K1: Understands the importance of COVID-19 pandemic. K2: Is ready to follow evidence-based medicine rules to strengthen his knowledge regarding COVID-19. K3: Is ready to perceive and recognize his own limitations in terms of knowledge, skills and social competences, and self-assessment of deficits and educational needs.

Metody dydaktyczne

Expository teaching methods: - informative seminars Self-education - reading literature

Rodzaj przedmiotu

przedmiot fakultatywny

Wymagania wstępne

none

Koordynatorzy przedmiotu

Michał Wiciński

Kryteria oceniania

Assessment methods:
- test

Assessment criteria:
- seminars: test – Pass: ≥60%; Fail: <60%

Praktyki zawodowe

not applicable’

Literatura

1. Siemieniuk R, Rochwerg B, Agoritsas T, Lamontagne F, Leo YS, Macdonald H, Agarwal A, Zeng L, Lytvyn L, Appiah JA, Amin W, Arabi Y, Blumberg L, Burhan E, Bausch FJ, Calfee CS, Cao B, Cecconi M, Chanda D, Cooke G, Du B, Dunning J, Geduld H, Gee P, Hashimi M, Hui DS, Kabra S, Kanda S, Kawano-Dourado L, Kim YJ, Kissoon N, Kwizera A, Laake JH, Machado FR, Mahaka I, Manai H, Mino G, Nsutedu E, Pshenichnaya N, Qadir N, Sabzwari S, Sarin R, Sharland M, Shen Y, Sri Ranganathan S, Souza J, Ugarte S, Venkatapuram S, Quoc Dat V, Vuyiseka D, Stegemann M, Wijewickrama A, Maguire B, Zeraatkar D, Bartoszko J, Ge L, Brignardello-Petersen R, Owen A, Guyatt G, Diaz J, Jacobs M, Vandvik PO. A living WHO guideline on drugs for covid-19. BMJ. 2020 Sep 4;370:m3379. doi: 10.1136/bmj.m3379. Update in: BMJ. 2020 Nov 19;371:m4475. PMID: 32887691.
2. Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, Pardo-Hernandez H, Rochwerg B, Lamontagne F, Han MA, Liu Q, Agarwal A, Agoritsas T, Chu DK, Couban R, Darzi A, Devji T, Fang B, Fang C, Flottorp SA, Foroutan F, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Hou X, Ibrahim Q, Khamis A, Lam B, Loeb M, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Neary JD, Qasim A, Rada G, Riaz IB, Sadeghirad B, Sekercioglu N, Sheng L, Sreekanta A, Switzer C, Tendal B, Thabane L, Tomlinson G, Turner T, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Ye Z, Guyatt GH, Brignardello-Petersen R. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 Jul 30;370:m2980. doi: 10.1136/bmj.m2980. Update in: BMJ. 2020 Sep 11;370:m3536. Update in: BMJ. 2020 Dec 17;371:m4852. PMID: 32732190; PMCID: PMC7390912.

Więcej informacji

Dodatkowe informacje (np. o kalendarzu rejestracji, prowadzących zajęcia, lokalizacji i terminach zajęć) mogą być dostępne w serwisie USOSweb:

Strona przedmiotu 1600-OG-EN-C19 w USOSweb